Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study demonstrated that intensive glucose control reduced the risk of developing diabetic peripheral neuropathy (DPN) and cardiovascular autonomic neuropathy (CAN). We evaluated multiple risk factors and phenotypes associated with DPN and CAN in this large, well-characterized cohort of participants with type 1 diabetes, followed for >23 years. DPN was defined by symptoms, signs, and nerve conduction study abnormalities in ≥2 nerves; CAN was assessed using standardized cardiovascular reflex tests. Generalized estimating equation models assessed the association of DPN and CAN with individual risk factors measured repeatedly. During DCCT/EDIC, 33% of participants developed DPN and 44% CAN. Higher mean HbA1c was the most significant risk factor for DPN, followed by older age, longer duration, greater height, macroalbuminuria, higher mean pulse rate, β-blocker use, and sustained albuminuria. The most significant risk factor for CAN was older age, followed by higher mean HbA1c, sustained albuminuria, longer duration of type 1 diabetes, higher mean pulse rate, higher mean systolic blood pressure, β-blocker use, estimated glomerular filtration rate <60 mL/min/1.73 m2, higher most recent pulse rate, and cigarette smoking. These findings identify risk factors and phenotypes of participants with diabetic neuropathy that can be used in the design of new interventional trials and for personalized approaches to neuropathy prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, persons who fail to return for continued anti-VEGF treatments are at risk of losing vision.537,538”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [538]
In the citing paper
“The prevalence of and risk factors for standard resting ECG-derived CAN were similar to previously reported estimates from CARTs.”
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · cited 1×
“LDL cholesterol was calculated using the Friedewald equation (17).”
Method(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationInternational Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Jyothi Kumar, M. V., & Chippada, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418 · cited 1×
“Although evidence for the benefit of b-blockers in modulating the impaired cardiac autonomic regulation during high sympathetic stress advocates for their use in patients with heart failure and/or post myocardial infarction (38), these agents are not currently recommended for the treatment of CAN (1).”
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602 · cited 2×
“Although evidence for the benefit of b-blockers in modulating the impaired cardiac autonomic regulation during high sympathetic stress advocates for their use in patients with heart failure and/or post myocardial infarction (38), these agents are not currently recommended for the treatment of CAN (1).”
BackgroundSelf-citationPrevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009
Dabelea, D., Mayer-Davis, E. J., Saydah, S., Imperatore, G., Linder, B., Divers, J., Bell, R., Badaru, A., Talton, J. W., Crume, T., et al. (2014) · JAMA · doi:10.1001/jama.2014.3201 · Cited by 1,412
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
Feldman, E. L., Nave, K.-A., Jensen, T. S., & Bennett, D. L. H. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.005 · Cited by 915 · cited 1×
“The mechanisms linking hypertension to DPN are unclear but may involve a complex set of pathways interlinking nerve function and energy production with a dysfunctional neural vascular supply (29).”
BackgroundSelf-citation2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2017.04.014 · Cited by 770
Research works printed but not linked: 1
- International Diabetes Federation. IDF Diabetes Atlas, 9th edition [Internet], 2019. Available from https://diabetesatlas.org
Cited by
Items 201–221 of 221
Adili, A., Aikemu, M., Rana, K. S., Wei, Y., Yusufu, A., & Jiang, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-19922-7
“…a significant association between increasing age and the risk of DPN. Similarly, findings from an epidemiological study on diabetic complications 25 and a survey conducted in Myanmar 26 also identified age as the most important risk factor for DPN, consistent with the current study’s results.”
Odayskyi, O. M., & Mityuryayeva-Kornijko, I. O. (2025) · Eastern Ukrainian Medical Journal · doi:10.21272/eumj.2025;13(3):780-794
Nawito, A. M., Menabbawy, S. A., Sayed, B. B. E., Magdy, M., & Khalil, A. S. (2026) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2026.111876 · Cited by 1
Nerve ultrasound in painful diabetic neuropathy: a pilot study of sural and tibial nerves
Alkotami, A. S., Elkholy, S. H., Elshamy, A. M., Fadel, W. A., El-Seidy, E. A. S., & Zhran, A. (2026) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-026-01123-2
“Previous studies reported similar results [18, 19].”
Wu, L., Na, R., & Qiu, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1822839
Pertile, P., D’Ippolito, I., Mascambroni, S., D’Amato, C., Andreadi, A., Lauro, D., & Spallone, V. (2026) · Endocrine · doi:10.1007/s12020-026-04613-8
Nerve Under Siege: Managing Diabetic Neuropathy and Pain
Alom, S., Ali, F., Abubakar, M., Yogi, S., & Bhat, H. R. (2026) · Springer eBooks · doi:10.1007/978-981-95-8946-3_3
Kong, Y., Zuo, F., Xuxiang, Z., Xu, Z., Hu, Y., & Nian, X. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1815912
Klowak, M., Bado, E., Reid-John, A., Dawood, R., Madakadze, C., & Boggild, A. K. (2026) · Brain Sciences · doi:10.3390/brainsci16060551
“The majority of the cohort studies investigated populations with peripheral neuropathy (PN) (7) [13,15,17,18,20,25,26], or broadly defined neuropathy (6) [12,19,21,23,24], with fewer examining polyneuropathy (PoN) (2) [14,16], and complex regional pain syndrome (CRPS) (1) [22].”
InfluentialReduced Tissue Oxygenation and Altered Valsalva Hemodynamics in Young Adults with Type 1 Diabetes
Poulsen, M. B., Julu, P. O. O., Memon, S., Shah, M., & Brock, C. (2026) · International Physiology Journal · doi:10.14302/issn.2578-8590.ipj-26-6121
Lee, P., Braffett, B. H., Chaytor, N. S., Bebu, I., Martin, C. L., Trapani, V. R., Luchsinger, J. A., Lorenzi, G. M., Pop‐Busui, R., Gubitosi‐Klug, R., et al. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doc25-0088
Self-citationMir, M. A., Nabi, S. U., Mir, R. A., Ali, S. I., Noorani, I. A., Muzzaffar, S., & Khurshid, I. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02547-w
“Recent evidence also indicates that chronic diabetes alters mRNA and microRNA expression in DRG neurons, with upregulation of pathways involved in inflammation, bioenergetics, and lipid metabolism [59, 60 ].”
Understanding Diabetic Neuropathy: From Pathophysiology to Therapeutic Targets
Eid, S., Rumora, A. E., Koubek, E. J., & Feldman, E. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00021-4
Self-citationHeart rate variability in adolescents with type 1 diabetes. A cross-sectional study
Koivikko, M. L., Helttula, K., Tulppo, M. P., Pokka, T. M.-L., Kallio, M., & Tossavainen, P. H. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02747-9
Ningrum, D. N. A., Muhtar, M. S., Widowati, E., Cahyati, W. H., Suhito, H. P., Sibarani, D. U., & Sholikun (2026) · BIO Web of Conferences · doi:10.1051/bioconf/202624702002
Chen, W. J., Zhou, J., & Peng, J. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01910-3
“Landmark clinical trials conducted in well-resourced medical settings have shown that sustained and stable glycemic control reduces the risk of neuropathy and other microvascular outcomes [5].”
Myosteatosis in type 1 diabetes: immunometabolic mechanisms, biomarkers, and therapeutic targets
Al‐Rashed, F., AlSaeed, H., Fennelly, K. P., Mulla, F. A., & Ahmad, R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1900161
Risk factors for diabetic peripheral neuropathy in diabetes mellitus patients: A case-control study
Sulastri, A., & Pribadi, I. (2026) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_1968_24
“[14] Among these variables, only self‑management compliance exhibited a statistically significant association with DPN incidence, reinforcing the central hypothesis of the research.”
Fridman, V. (2026) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/cont.0000000000001744
Gliflozins in the treatment of diabetes and its complications
Žák, P., Kvíčalová, K., & Ambrožová, E. (2026) · Klinická farmakologie a farmacie · doi:10.36290/far.2026.023
Lim, L., Foo, S. H., Ghani, R. A., Ibrahim, L., Wahab, N. A., Mohamed, W. M. I. W., Lim, S.-C., Mustafa, N., Hew, F., Hussein, Z. B., et al. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01927-8
Metadata
- Authors
- Braffett, B. H., Gubitosi-Klug, R. A., Albers, J. W., Feldman, E. L., Martin, C. L., White, N. H., Orchard, T. J., Lopes-Virella, M., Lachin, J. M., Pop-Busui, R., & the DCCT/EDIC Research Group
- Affiliations
- George Washington University (US)
- Rainbow Babies & Children’s Hospital, Case Western Reserve University, Cleveland, OH
- University of Michigan (US)
- Washington University in St. Louis (US)
- University of Pittsburgh (US)
- Medical University of South Carolina (US)
- University of Michigan Medical School, Ann Arbor, MI
- Corresponding author
- Braffett, Barbara H.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2020-02-12
- Volume
- 69
- Issue
- 5
- Pages
- 1000-1010
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC7171957
- OpenAlex
- W3006227931
- Cited by
- 221
- References
- 40
- Citations by year
- 2026: 26 · 2025: 41 · 2024: 45 · 2023: 31 · 2022: 40 · 2021: 24 · 2020: 14
- FWCI
- 20.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u01dk094157-13, UL1TR002345)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK094176, U01-DK094157, P30DK092926, P30DK020572, P30DK017047)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- diabetic peripheral neuropathy, cardiac autonomic neuropathy, type 1 diabetes, risk factors, tight glycemic control, HbA1c, albuminuria, macroalbuminuria, beta-blocker use, pulse rate, cigarette smoking, neuropathy prevention, DCCT/EDIC
- MeSH terms
- Adult, Autonomic Nervous System, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Female, Glycated Hemoglobin, Humans, Longitudinal Studies, Male, Risk Factors, Cohort Studies, Multivariate Analysis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.